ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS
· Real-Time Price · USD
0.45
0.03 (7.02%)
At close: May 06, 2025, 3:59 PM
0.42
-5.17%
After-hours: May 06, 2025, 07:59 PM EDT
7.02% (1D)
| Bid | 0.42 |
| Market Cap | 5.04M |
| Revenue (ttm) | 8.01M |
| Net Income (ttm) | -7.13M |
| EPS (ttm) | -13.83 |
| PE Ratio (ttm) | -0.03 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.46 |
| Volume | 3,612,506 |
| Avg. Volume (20D) | 18,440,316 |
| Open | 0.40 |
| Previous Close | 0.42 |
| Day's Range | 0.40 - 0.47 |
| 52-Week Range | 0.30 - 29.00 |
| Beta | 2.12 |
About RSLS
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investi...
Industry Medical - Devices
Sector Healthcare
IPO Date Oct 6, 2016
Employees 17
Stock Exchange NASDAQ
Ticker Symbol RSLS
5 days ago
+23.89%
ReShape Lifesciences shares are trading higher aft...
Unlock content with
Pro Subscription
2 weeks ago
+23.73%
ReShape Lifesciences shares are trading higher after the company announced it received a Notice of Allowance for a patent from the USPTO.
